US Oncology Director of Business Development Salaries in Fort Worth, TX
The average US Oncology Director of Business Development in Fort Worth, TX earns an estimated $209,652 annually, which includes an estimated base salary of $159,905 with a $49,747 bonus. US Oncology's Director of Business Development compensation is $43,350 more than the US average for a Director of Business Development. Director of Business Development salaries at US Oncology in Fort Worth, TX can range from $73,000 - $390,000.
In Fort Worth, TX, The Business Development Department at US Oncology earns $11,664 more on average than the Customer Support Department.
Last updated 7 months ago.
- $159,905
- avg. base
- $49,747
- avg. bonus
Director of Business Development Salaries at US Oncology
In Fort Worth, TX, Directors of Business Development earn $3,056 more than Directors of Business Development.
Compensation at US Oncology by Department
In Fort Worth, TX, The Business Development Department averages $11,664 more than the Customer Support Department, and $493 less than the Sales Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to US Oncology reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to US Oncology reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at US Oncology Rate Their Compensation
The majority of Directors of Business Development at US Oncology believe they're compensated fairly. 50% of Directors of Business Development at US Oncology say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at US Oncology
